The Avellino SARS-CoV-2/COVID-19 Test (AvellinoCoV2) is a non-invasive, swab based test used to detect the SARS-CoV-2 virus, a strong indicator of the patient having the COVID-19 disease. A positive result generally indicates an active infection, while a negative result should not be used as the sole basis for treatment or other patient management decisions.
All results, whether positive or negative, must be combined with clinical observations, patient history, and epidemiological information for a proper medical diagnosis. AvellinoCoV2 was developed by Avellino Lab USA, Inc., in its CLIA-qualified lab and is authorized by the FDA under the Emergency Use Authorization.
Health care provider orders and receives the AvellinoCoV2 test kit.
Health care provider collects swab samples from the patient’s nose and mouth.
Health care provider ships the patient's sample to Avellino’s laboratory.
Avellino conducts lab testing.
Avellino prepares the patient report. Sample Negative Patient Report Sample Positive Patient Report
Avellino sends the results to your health care provider.
Find out how Avellino partnered with other companies to create a comprehensive corporate testing solution for returning to work. Visit lifesite.co for more information.
By accessing and using this site, you consent to the use of cookies as described in our Privacy Policy